David R. Lorenz

2.3k citations

38 papers · 1.7k indexed · 1 hit paper · h-index 18

Co-authors: James J. Collins Timothy S. Gardner Diego di Bernardo Dana Gabuzda Vikas Misra Susan Morgello Sukrutha Chettimada Shibani S. Mukerji
Topics: HIV Research and Treatment (8 papers)HIV-related health complications and treatments (7 papers)HIV/AIDS Research and Interventions (7 papers)
Cited by: Virology Aging Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States South Africa Italy

In The Last Decade

David R. Lorenz

37 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inferring Genetic Networks and Identifying Compound Mode of Action via Expression Profiling

2003 810 citations David R. Lorenz et al. profile →

Peers

Countries citing papers authored by David R. Lorenz

Since Specialization

Citations

This map shows the geographic impact of David R. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Lorenz more than expected).

Fields of papers citing papers by David R. Lorenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Lorenz. The network helps show where David R. Lorenz may publish in the future.

Co-authorship network of co-authors of David R. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Lorenz. A scholar is included among the top collaborators of David R. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Lorenz. David R. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes 2021 ·Molecular Cancer Research ·(unknown),David R. Lorenz,Kent W. Mouw,Alan D. D’Andrea,Dana Gabuzda	12
2	Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults 2021 ·EClinicalMedicine ·David R. Lorenz,Vikas Misra,Sukrutha Chettimada,Hajime Uno,Lanqing Wang,Benjamin C. Blount,Víctor R. De Jesús,Benjamin B. Gelman,Susan Morgello,Steven M. Wolinsky,Dana Gabuzda	12
3	Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients 2020 ·BMC Immunology ·Sukrutha Chettimada,David R. Lorenz,Vikas Misra,Steven M. Wolinsky,Dana Gabuzda	41
4	White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy 2019 ·Molecular Neurobiology ·Isaac H. Solomon,Sukrutha Chettimada,Vikas Misra,David R. Lorenz,Robert J. Gorelick,Benjamin B. Gelman,Susan Morgello,Dana Gabuzda	26
5	Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men 2018 ·Cancer Causes & Control ·(unknown),Hajime Uno,David R. Lorenz,Steven M. Wolinsky,Dana Gabuzda	6
6	Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection 2018 ·AIDS ·(unknown),David R. Lorenz,Vikas Misra,Hajime Uno,Dana Gabuzda	13
7	Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy 2018 ·Scientific Reports ·Sukrutha Chettimada,David R. Lorenz,Vikas Misra,Simon T. Dillon,R. Keith Reeves,Cordelia Manickam,Susan Morgello,Gregory D. Kirk,Shruti H. Mehta,Dana Gabuzda	117
8	Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy 2018 ·AIDS ·Debjani Guha,Shibani S. Mukerji,Sukrutha Chettimada,Vikas Misra,David R. Lorenz,Susan Morgello,Dana Gabuzda	44
9	Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States 2018 ·Clinical Infectious Diseases ·Shibani S. Mukerji,Vikas Misra,David R. Lorenz,Hajime Uno,Susan Morgello,Donald Franklin,Ronald J. Ellis,Scott Letendre,Dana Gabuzda	49
10	Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine 2017 ·AIDS and Behavior ·Shibani S. Mukerji,Roxanna Haghighat,Vikas Misra,David R. Lorenz,Alex Holman,(unknown),Dana Gabuzda	9
11	Long-term nitrite inhalant exposure and cancer risk in MSM 2017 ·AIDS ·(unknown),Hajime Uno,Alex Holman,David R. Lorenz,Steven M. Wolinsky,Dana Gabuzda	10
12	Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study 2017 ·Cancer Causes & Control ·(unknown),Hajime Uno,Alex Holman,David R. Lorenz,Dana Gabuzda	7
13	Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults 2017 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Shibani S. Mukerji,Vikas Misra,David R. Lorenz,Anna M. Cervantes‐Arslanian,Jennifer Lyons,Spyridon Chalkias,Alysse G. Wurcel,(unknown),Nagagopal Venna,Susan Morgello,Igor J. Koralnik,Dana Gabuzda	44
14	Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy 2016 ·Clinical Infectious Diseases ·Shibani S. Mukerji,Joseph J. Locascio,Vikas Misra,David R. Lorenz,Alex Holman,(unknown),Sudhir Penugonda,Steven M. Wolinsky,Dana Gabuzda	27
15	Multifaceted Genome Control by Set1 Dependent and Independent of H3K4 Methylation and the Set1C/COMPASS Complex 2014 ·PLoS Genetics ·(unknown),(unknown),Fiona B. Tamburini,David R. Lorenz,Hugh P. Cam	30
16	Heterochromatin assembly and transcriptome repression by Set1 in coordination with a class II histone deacetylase 2014 ·eLife ·David R. Lorenz,(unknown),(unknown),Michelle M. Meyer,Hugh P. Cam	23
17	Set1 cooperates with CENP-B in genome organization and transcriptome regulation 2013 ·Epigenetics & Chromatin ·David R. Lorenz,(unknown),(unknown),Peter Johansen,(unknown),Shiv I. S. Grewal,Hugh P. Cam	7
18	ELISA: Structure-Function Inferences based on statistically significant and evolutionarily inspired observations 2003 ·BMC Bioinformatics ·Boris E. Shakhnovich,(unknown),(unknown),David R. Lorenz,Charles DeLisi,Eugene I. Shakhnovich	14
19	Role of a JAK3-dependent Biochemical Signaling Pathway in Platelet Activation and Aggregation 2001 ·Journal of Biological Chemistry ·Heather Tibbles,Alexei Vassilev,(unknown),(unknown),Dan Zhu,David R. Lorenz,Barbara Waurzyniak,Xingping Liu,Fatih M. Uckun	44
20	High Pressure Liquid Chromatographic Determination of Methomyl and Oxamyl on Vegetable Crops 1978 ·Journal of AOAC INTERNATIONAL ·(unknown),(unknown),David R. Lorenz,(unknown)	1

About David R. Lorenz

David R. Lorenz is a scholar working on Virology, Biological Psychiatry and Emergency Medicine, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV-related health complications and treatments (7 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (211 citations), Aging (32 citations) and Molecular Biology (1.1k citations). David R. Lorenz has collaborated with scholars based in United States, South Africa and Italy. Frequent co-authors include James J. Collins, Timothy S. Gardner, Diego di Bernardo, Dana Gabuzda, Vikas Misra, Susan Morgello, Sukrutha Chettimada, Shibani S. Mukerji, John R. Wasson and Hajime Uno. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact